Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema

5 months ago 32
Read Entire Article
  1. Homepage
  2. Finance
  3. Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema

Related

DA Davidson raises Nebius Group stock price target to $65 on non-core business potential

DA Davidson raises Nebius Group stock price target to $65 on...

17 minutes ago 0
Balchem stock price target raised to $189 from $180 at H.C. Wainwright

Balchem stock price target raised to $189 from $180 at H.C. ...

17 minutes ago 0
Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook

Organon shares surge over 8% as Q2 earnings top estimates, r...

17 minutes ago 0

Trending

1. 10 year treasury
2. uttarkashi
3. squawk box
4. patriots schedule
5. weather dc
6. comm stock
7. baltimore weather
8. brittney griner banned from wnba
9. mn vikings
10. cat stock

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 419
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 204
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 184
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 148
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

6 months ago 143
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved